Individual differences in vulnerability for self-injurious behavior: Studies using an animal model

Behavioural Brain Research

Volumn 217, Issue 1, 2011, Pages 148-154

  Muehlmann, Amber M ^a   Wilkinson, Jennifer A ^a   Devine, Darragh P ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Animal model; Autism; Individual differences; Lesch Nyhan syndrome; Self injurious behavior; Stress

Indexed keywords

PEMOLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMUTILATION; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; ENVIRONMENTAL STRESS; GROOMING; LOCOMOTION; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; REARING; STEREOTYPY; TISSUE INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; INDIVIDUALITY; MALE; MOTOR ACTIVITY; PEMOLINE; RATS; RATS, LONG-EVANS; SELF-INJURIOUS BEHAVIOR; STEREOTYPED BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 78149340444     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.10.012     Document Type: Article

References (59)

1. Anderson L.T., Ernst M. Self-injury in Lesch-Nyhan disease. J Autism Dev Disord 1994, 24:67-81.
2. Anderson L.T., Ernst M., Davis S.V. Cognitive abilities of patients with Lesch-Nyhan disease. J Autism Dev Disord 1992, 22:189-203.
3. Baghdadli A., Pascal C., Grisi S., Aussilloux C. Risk factors for self-injurious behaviors among 222 young children with autistic disorders. J Intellect Disabil Res 2003, 47:622-627.
4. Blake B.L., Muehlmann A.M., Egami K., Breese G.R., Devine D.P., Jinnah H.A. Nifedipine suppresses self-injurious behaviors in animals. Dev Neurosci 2007, 29:241-250.
5. Breese G.R., Knapp D.J., Criswell H.E., Moy S.S., Papadeas S.T., Blake B.L. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Brain Res Rev 2005, 48:57-73.
6. Brucke T., Sofic E., Killian W., Rett A., Riederer P. Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study. J Neural Transm 1987, 68:315-324.
7. Clarke D.J., Waters J., Corbett J.A. Adults with Prader-Willi syndrome: abnormalities of sleep and behavior. J R Soc Med 1989, 82:21-24.
8. Cromwell H.C., King B.H. The role of the basal ganglia in the expression of stereotyped, self-injurious behaviors in developmental disorders. Int Rev Res Ment Retard 2004, 29:119-158.
9. Cromwell H.C, King B.H., Levine M.S. Pemoline alters dopamine modulation of synaptic responses of neostriatal neurons in vitro. Dev Neurosci 1997, 19:497-504.
10. Cromwell H.C., Levine M.S., King B.H. Cortical damage enhances pemoline-induced self-injurious behavior in prepubertal rats. Pharmacol Biochem Behav 1999, 62:223-227.
11. Davenport M.D., Lutz C.K., Tiefenbacher S., Novak M.A., Meyer J.S. A rhesus monkey model of self-injury: effects of relocation stress on behavior and neuroendocrine function. Biol Psychiatry 2008, 63:990-996.
12. Dellinger-Ness L.A., Handler L. Self-injurious behavior in human and non-human primates. Clin Psychol Rev 2006, 26:503-514.
13. Dellu F., Piazza P.V., Mayo W., Le Moal M., Simon H. Novelty-seeking in rats - Biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology 1996, 34:136-145.
14. Devine D.P., Muehlmann A.M. Tiermodelle für selbstverletzendes Verhalten (Animal models of self-injurious behavior). Selbstverletzendes verhalten bei stressassoziierten erkrankungen (Self-injurious behavior in stress-associated disorders) 2009, 39-60. Verlag W. Kohlhammer, Stuttgart Germany. C. Schmahl, C. Stiglmayr (Eds.).
15. Dietz D.M., Tapocik J., Gaval-Cruz M., Kabbaj M. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine. Physiol Behav 2005, 86:347-355.
16. Dunn A.J, Swiergiel A.H., Palamarchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann N Y Acad Sci 2004, 1018:25-34.
17. Ernst M., Zametkin A.J., Matochik J.A., Pascualvaca D., Cohen R.M. Low medial prefrontal dopaminergic activity in autistic children. Lancet 1997, 350:638.
18. Findling R.L. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. J Clin Psychiatry 2005, 66(Suppl 10):26-31.
19. Fuller R.W., Perry K.W., Bymaster F.P., Wong D.T. Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats. J Pharm Pharmacol 1978, 30:197-198.
20. Gilbert J.C, Allen J.M., Townsend B.G., Wyllie M.G. Drugs affecting the central nervous system: effects of pemoline and tricyclic antidepressants on nerve terminal adenosine triphosphatase activities and neurotransmitter release. Neuropharmacology 1978, 17:419-421.
21. Gillberg C., Svennerholm L. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 1987, 151:89-94.
22. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wikstrom A.C., et al. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Natl Acad Sci U S A 1986, 83:9779-9783.
23. Hartley S.L., Maclean W.E., Butler M.G., Zarcone J., Thompson T. Maladaptive behaviors and risk factors among the genetic subtypes of Prader-Willi syndrome. Am J Med Genet A 2005, 136:140-145.
24. Hooks M.S., Colvin A.C., Juncos J.L., Justice J.B. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res 1992, 587:306-312.
25. Hooks M.S., Jones G.H., Neill D.B., Justice J.B. Individual differences in amphetamine sensitization: dose-dependent effects. Pharmacol Biochem Behav 1992, 41:203-210.
26. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Individual differences in locomotor activity and sensitization. Pharmacol Biochem Behav 1991, 38:467-470.
27. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse 1991, 9:121-128.
28. 2 receptors and mRNAs. J Neurosci 1994, 14:6144-6152.
29. Iwata B., Roscoe E.M., Zarcone J., Richman D.M. Environmental determinants of self-injurious behavior. Self-injurious behavior: gene-brain-behavior relationships 2002, 99-103. American Psychological Association, Washington, D.C. S.R. Schroeder, M.L. Oster-Granite, T. Thompson (Eds.).
30. Iwata B.A., Pace G.M., Dorsey M.F., Zarcone J.R., Vollmer T.R., Smith R.G., et al. The functions of self-injurious behavior: an experimental-epidemiological analysis. J Appl Behav Anal 1994, 27:215-240.
31. Jama A., Cecchi M., Calvo N., Watson S.J., Akil H. Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test. Psychopharmacology (Berl) 2008, 198:333-340.
32. Joyce P.R., McHugh P.C., McKenzie J.M., Sullivan P.F., Mulder R.T., Luty S.E., et al. A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychol Med 2006, 36:807-813.
33. Kabbaj M. Individual differences in vulnerability to drug abuse: the high responders/low responders model. CNS Neurol Disord Drug Targets 2006, 5:513-520.
34. Kabbaj M., Devine D.P., Savage V.R., Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 2000, 20:6983-6986.
35. Kabbaj M., Evans S., Watson S.J., Akil H. The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences. Neuropharmacology 2004, 47(Suppl 1):111-122.
36. Kabbaj M., Norton C.S., Kollack-Walker S., Robinson T.E., Watson S.J., Akil H. Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine taking-behavior. Psychopharmacology 2001, 158:382-387.
37. Kemp A.S., Fillmore P.T., Lenjavi M.R., Lyon M., Chicz-DeMet A., Touchette P.E., et al. Temporal patterns of self-injurious behavior correlate with stress hormone levels in the developmentally disabled. Psychiatry Res 2008, 157:181-189.
38. Kies S.D., Devine D.P. Self-injurious behavior: a comparison of caffeine and pemoline models in rats. Pharmacol Biochem Behav 2004, 79:587-598.
39. King B.H., Au D., Poland R.E. Pretreatment with MK-801 inhibits pemoline-induced self-biting behavior in prepubertal rats. Dev Neurosci 1995, 17:47-52.
40. Li Y., Hu X.T., Berney T.G., Vartanian A.J., Stine C.D., Wolf M.E., et al. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 1999, 34:169-180.
41. Lloyd K.G., Hornykiewicz O., Davidson L., Shannak K., Farley I., Goldstein M., et al. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Eng J Med 1981, 305:1106-1111.
42. Matson J.L., Minshawi N.F., Gonzalez M.L., Mayville S.B. The relationship of comorbid problem behaviors to social skills in persons with profound mental retardation. Behav Modif 2006, 30:496-506.
43. Matson J.L., Nebel-Schwalm M. Assessing challenging behaviors in children with autism spectrum disorders: a review. Res Dev Disabil 2007, 28:567-579.
44. Muehlmann A.M., Brown B.D., Devine D.P. Pemoline-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy. J Pharmacol Exp Ther 2008, 324:214-223.
45. Muehlmann A.M., Devine D.P. Glutamate-mediated neuroplasticity in an animal model of self-injurious behavior. Behav Brain Res 2008, 189:32-40.
46. Muehlmann A.M., Wolfman S., Devine D.P. Examining the effects of chronic stress on self-injurious behavior in an animal model. Soc Neurosci 2008, 34:446-529. Abstracts.
47. Novak M.A. Self-injurious behavior in rhesus monkeys: new insights into its etiology, physiology, and treatment. Am J Primatol 2003, 59:3-19.
48. Piazza P.V, Deminière J.-M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
49. Rojahn J., Esbensen A.J. Epidemiology of self-injurious behavior in mental retardation: A review. Self-injurious behavior: gene-brain-behavior relationships 2002, 41-77. American Psychological Association, Washington, D.C. S.R. Schroeder, M.L. Oster-Granite, T. Thompson (Eds.).
50. Rougé-Pont F., Deroche V., Le Moal M., Piazza P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci 1998, 10:3903-3907.
51. Rougé-Pont F., Piazza P.V., Kharouby M., Le Moal M., Simon H. Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration: a microdialysis study. Brain Res 1993, 602:169-174.
52. Saito Y., Ito M., Hanaoka S., Ohama E., Akaboshi S., Takashima S. Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study. Neuropediatrics 1999, 30:66-71.
53. Sandman C.A., Barron J.L., Chicz-DeMet A., DeMet E.M. Plasma β-endorphin levels in patients with self-injurious behavior and stereotypy. Am J Ment Retard 1990, 95:84-92.
54. Stead J.D.H., Clinton S., Neal C., Schneider J., Jama A., Miller S., et al. Selective breeding for divergence in novelty-seeking traits: heritability and enrichment in spontaneous anxiety-related behaviors. Behav Genet 2006, 36:697-712.
55. Stodgell C.J., Loupe P.S., Schroeder S.R., Tessel R.E. Cross-sensitization between footshock stress and apomorphine on self-injurious behavior and neostriatal catecholamines in a rat model of Lesch-Nyhan syndrome. Brain Res 1998, 783:10-18.
56. Symons F.J., Butler M.G., Sanders M.D., Feurer I.D., Thompson T. Self-injurious behavior and Prader-Willi syndrome: behavioral forms and body locations. Am J Ment Retard 1999, 104:260-269.
57. Symons F.J., Sutton K.A., Walker C., Bodfish J.W. Altered diurnal pattern of salivary substance P in adults with developmental disabilities and chronic self-injury. Am J Ment Retard 2003, 108:13-18.
58. Tordjman S., Anderson G.M., McBride P.A., Hertzig M.E., Snow M.E., Hall L.M., et al. Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 1997, 38:705-715.
59. Xiao-Mian S, Jing Y., Chongxuna Z., Min L., Hui-Xing D. Study of 99mTc-TRODAT-1 imaging on human brain with children autism by single photon emission computed tomography. Conf Proc IEEE Eng Med Biol Soc 2005, 5:5328-5330.